← All trials
NCT06538012
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 20, 2024
- Primary completion
- Sep 10, 2026
- Completion date
- Dec 28, 2026
- First posted
- Aug 5, 2024
- Last posted
- Oct 15, 2024
- Enrollment
- 85
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Essen BiotechLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.